8. Zmírnění místních projevů radiační dermatitidy v průběhu onkologické léčby
fáze 1
fáze 2
Indikace DebriEcaSan Alfa – přehled literatury
- Rosenthal A, Israilevich R, Moy R. Management of acute radiation dermatitis: A review of the literature and proposal for treatment algorithm. J Am Acad Dermatol. 2019 Aug;81(2):558 - 567. doi: 10.1016/j.jaad.2019.02.047. Epub 2019 Feb 22. PMID: 30802561.
- Yang X, Ren H, Guo X, Hu C, Fu J. Radiation-induced skin injury: pathogenesis, treatment, and management. Aging (Albany NY). 2020 Nov 16;12(22):23379-23393. doi: 10.18632/aging.103932. Epub 2020 Nov 16. PMID: 33202382; PMCID: PMC7746368.
- Tai RZ, Loh EW, Tsai JT, Tam KW. Effect of hyaluronic acid on radiotherapy-induced mucocutaneous side effects: a meta-analysis of randomized controlled trials. Support Care Cancer. 2022 Jun;30(6):4845-4855. doi: 10.1007/s00520-022-06902-0. Epub 2022 Feb 12. PMID: 35152333.
- Jandova J, Snell J, Hua A, Dickinson S, Fimbres J, Wondrak GT. Topical hypochlorous acid (HOCl) blocks inflammatory gene expression and tumorigenic progression in UV-exposed SKH-1 high risk mouse skin. Redox Biol. 2021 Sep;45:102042. doi: 10.1016/j.redox.2021.102042. Epub 2021 Jun 11. PMID: 34144392; PMCID: PMC8217684.
- Leung TH, Zhang LF, Wang J, Ning S, Knox SJ, Kim SK. Topical hypochlorite ameliorates NF-κB mediated skin diseases in mice. J Clin Invest. 2013 Dec;123(12):5361-70. doi: 10.1172/JCI70895. Epub 2013 Nov 15. PMID: 24231355; PMCID: PMC3859383.
